Scinovex

Research article · 2017 · Full text

International Journal of Veterinary Sciences and Animal Husbandry

Efficacy of inactivated new castle disease vaccine through in ovo vaccination

Surajit BaksiNirav RaoPravinsinh ChauhanPriya MalsariaMukandar Khan

Volume 2(5) · Pages 27–29

Research areasVirology and Viral DiseasesMicrobial infections and disease researchAnimal Virus Infections Studies

↓ Read full-text PDF0 citations

Abstract

Author-written

Newcastle disease is a highly prevalent disease of poultry industry all over the world. It causes high economic losses to farmers. Vaccination has been ideal and successful method for prevention of the disease. Many live and inactivated vaccines are available commercially for control of disease. But, major limitation of vaccination method is susceptibility of infection between time of hatch and vaccination. Hence, in ovo vaccination method was developed as alternative method. In present study, 30 specific pathogen free (SPF) embryonated eggs were inoculated with inactivated Newcastle disease vaccine and 30 eggs were kept as control. After 21 days of vaccination, the hatched birds were challenged with virulent strain of Newcastle disease. The antibodies against Newcastle disease were measured by haemagglutination-inhibition (HI) method at various time intervals. The results reported that in ovo vaccination method was efficient to protect the birds from disease.

Summary

Source-checked

Plain-language reading of the full paper, prepared with AI and checked against the text. Each point links to the authors' own words.

  1. Why it matters

    • Newcastle disease is a widespread poultry ailment that results in significant economic losses for farmers globally. View evidence ↗

      Why it matters

      Newcastle disease is a widespread poultry ailment that results in significant economic losses for farmers globally.

      In the paper's own words

      “Newcastle disease is a highly prevalent disease of poultry industry all over the world. It causes high economic losses to farmers.”

      Page 1

      Found in: Introduction

      Read it in the full textOpen PDF at page 1 ↗
    • The disease is highly severe, capable of causing up to 100% morbidity and mortality in chicks of any age. View evidence ↗

      Why it matters

      The disease is highly severe, capable of causing up to 100% morbidity and mortality in chicks of any age.

      In the paper's own words

      “ND can cause morbidity and mortality up to 100% of the chicks affecting any age group.”

      Page 1

      Found in: Introduction

      Read it in the full textOpen PDF at page 1 ↗
    • A primary drawback of standard vaccination is that birds remain susceptible to infection in the window between hatching and receiving the vaccine. View evidence ↗

      Why it matters

      A primary drawback of standard vaccination is that birds remain susceptible to infection in the window between hatching and receiving the vaccine.

      In the paper's own words

      “But, major limitation of vaccination method is susceptibility of infection between time of hatch and vaccination.”

      Page 1

      Found in: Introduction

      Read it in the full textOpen PDF at page 1 ↗
  2. The question

    • The study aimed to evaluate if in ovo vaccination using an inactivated Newcastle disease (ND) vaccine is suitable and effective in protecting chicks. View evidence ↗

      The question

      The study aimed to evaluate if in ovo vaccination using an inactivated Newcastle disease (ND) vaccine is suitable and effective in protecting chicks.

      In the paper's own words

      “This study was designed to determine the suitability of in ovo vaccination with inactivated ND vaccine and efficacy of the vaccine to protect chicks from ND through serum antibody titre estimation and challenge study.”

      Page 1

      Found in: Introduction

      Read it in the full textOpen PDF at page 1 ↗
  3. What they did

    • Vaccinated eggs received 0.2 ml of inactivated Newcastle Disease vaccine via the in ovo route on the 18th day of hatching. View evidence ↗

      What they did

      Vaccinated eggs received 0.2 ml of inactivated Newcastle Disease vaccine via the in ovo route on the 18th day of hatching.

      In the paper's own words

      “At 18th day of hatching, eggs from group 1 were inoculated with 0.2 ml Newcastle Disease Vaccine, Inactivated (procured from Hester Biosciences Limited, Ahmedabad) through in-ovo route carefully.”

      Page 2

      Found in: Study design

      Read it in the full textOpen PDF at page 2 ↗
    • Antibody levels were measured using the Haemagglutination-Inhibition (HI) test on serum collected at 3, 7, 14, 21, 28, 35, and 42 days post-vaccination. View evidence ↗

      What they did

      Antibody levels were measured using the Haemagglutination-Inhibition (HI) test on serum collected at 3, 7, 14, 21, 28, 35, and 42 days post-vaccination.

      In the paper's own words

      “Serum was collected at 03 (at the time of hatch), 07, 14, 21, 28, 35 and 42 days post vaccination. Haemaglutination-Inhibition test was performed to estimate present of antibodies against Newcastle disease.”

      Page 2

      Found in: Study design

      Read it in the full textOpen PDF at page 2 ↗
  4. What they found

    • The in ovo vaccination procedure did not affect hatching, as 100% hatchability was observed in both the vaccinated and control groups. View evidence ↗

      What they found

      The in ovo vaccination procedure did not affect hatching, as 100% hatchability was observed in both the vaccinated and control groups.

      In the paper's own words

      “There was 100% hatchability observed in all vaccinated and control chicks and chicks were found healthy at time of hatch.”

      Page 2

      Found in: Results

      Read it in the full textOpen PDF at page 2 ↗
    • Vaccinated chicks showed neonatal protection at hatching with an HI titre of 1.33 ± 0.08, while the control group had a titre of 0. View evidence ↗

      What they found

      Vaccinated chicks showed neonatal protection at hatching with an HI titre of 1.33 ± 0.08, while the control group had a titre of 0.

      In the paper's own words

      “Oil emulsion vaccine against Newcastle Disease could produce neonatal protection from day of hatching as the results show that antibody HI titre was obtained as 1.33 ± 0.08 as compared to that of control which was found 0 throughout the study.”

      Page 2

      Found in: Discussion

      Read it in the full textOpen PDF at page 2 ↗
    • Following the viral challenge, all control birds died within 4 days, whereas vaccinated birds showed no signs of disease and zero mortality. View evidence ↗

      What they found

      Following the viral challenge, all control birds died within 4 days, whereas vaccinated birds showed no signs of disease and zero mortality.

      In the paper's own words

      “Birds vaccinated with ND vaccine did not show any signs of disease and no mortality was observed. All control birds died within 4 days of challenge with post mortem signs of Newcastle Disease.”

      Page 2

      Found in: Results

      Read it in the full textOpen PDF at page 2 ↗
  5. What it means

    • The authors highlight that in ovo vaccination provides the advantages of neonatal protection, fewer side effects, and reduced labor costs. View evidence ↗

      What it means

      The authors highlight that in ovo vaccination provides the advantages of neonatal protection, fewer side effects, and reduced labor costs.

      In the paper's own words

      “In ovo vaccination has advantage of neonatal protection with less side effects and decreased labour cost.”

      Page 2

      Found in: Conclusion

      Read it in the full textOpen PDF at page 2 ↗

Figures & tables

From the original paper
Serum antibody titre (log2 HI units) against Newcastle disease after in ovo vaccination (n=30)Table 1Page 2
FULL TEXT Original article · reflowed for reading

Introduction

Newcastle disease (ND) is endemic in many countries since it was found first time in 1926 [1,2,3] . The disease is commonly known as Ranikhet Disease in India [4,5] . ND is caused by Avian Paramyxovirus type 1 (APMV-1) from Paramyxoviridae family. There are different types of ND virus like velogenic, mesogenic and lentogenic depending upon severity and lesions [6] . ND can cause morbidity and mortality up to 100% of the chicks affecting any age group. Economically also, ND is a major poultry disease and threat to poultry industry [4,7,8] . The severity of infection and symptoms are dependent on virulence, host, age, immune status, other diseases and environmental condition [9] . ND occurs in a wide range of hosts (241 species) and almost all species of birds are affected [10] . General approaches to control ND are hygiene and vaccination. Hygiene includes cleaning, sanitation, limited access of wild birds and personnel hygiene. Vaccination with proper biosecurity measures is most effective tool to control ND [11] . ND can be eradicated by vaccination, but still is not practised in a few countries on a commercial scale [12,13,14] . There are many approaches for ND vaccination through live vaccines and inactivated vaccines by different routes of administration, but still there are limitation of successful vaccination like early exposure to disease after hatching. Recently, novel approach of in ovo vaccination has been developed to prevent the occurrence of several poultry diseases [15,16] . In ovo vaccination has several advantages like neonatal resistance, uniform doses, better protection, reduction in labour cost, etc [17,18] . This study was designed to determine the suitability of in ovo vaccination with inactivated ND vaccine and efficacy of the vaccine to protect chicks from ND through serum antibody titre estimation and challenge study.

Material and methods

Material and methods

Study design

Sixty healthy specific pathogen free (SPF) embryonated eggs were selected and divided in to two groups as under: Group 1: Eggs vaccinated with Newcastle Disease Vaccine, Inactivated (30 nos) Group 2: Eggs kept as control without vaccination (30 nos) SPF eggs were procured from Venkey's India Limited, Pune and no antibodies against Newcastle Disease (ND) were present in them. Eggs were kept in hatcher until 21 days of hatching. At 18 th day of hatching, eggs from group 1 were inoculated with 0.2 ml Newcastle Disease Vaccine, Inactivated (procured from Hester Biosciences Limited, Ahmedabad) through in-ovo route carefully. Eggs from group 2 were kept as control and not treated with any vaccine throughout the study. After hatching, young chicks from both the groups were kept in in deep litter designated rooms separately so that cross contamination can be prevented. Chicks were kept in controlled environment and fed with healthy diet and pure water. After 21 days of vaccination, all birds were challenged with 10 5 LD 50 of virulent strain of Newcastle disease virus intramuscularly. Birds were observed for 14 days after challenge for any clinical signs. Dead birds were sent for examination of post-mortem signs of Newcastle disease.

Serum was collected at 03 (at the time of hatch), 07, 14, 21, 28, 35 and 42 days post vaccination. Haemaglutination-Inhibition test was performed to estimate present of antibodies against Newcastle disease.

Data analysis

All data were entered in to Microsoft Excel Worksheet, 2013 and represented as mean ± SEM where necessary. Statistical analysis was performed by one way ANOVA method using Microsoft Excel software and p value less than 0.05 was considered as significantly different data with 95% confidence interval.

Results

There was 100% hatchability observed in all vaccinated and control chicks and chicks were found healthy at time of hatch. After vaccination, serum was collected from chicks at 03 days (at time of hatch), 07, 14, 21, 28, 35 and 42 days. Serum antibody titre against Newcastle disease was measured in log 2 as presented in Table 1. Birds from both groups were challenged after 21 days of vaccination and observed for 14 days post challenge. Birds vaccinated with ND vaccine did not show any signs of disease and no mortality was observed. All control birds died within 4 days of challenge with post mortem signs of Newcastle Disease.

Table 1. Serum antibody titre (log2 HI units) against Newcastle disease after in ovo vaccination (n=30)
Group nameDays post vaccination (Birds were challenged at 21 days post vaccination)——————
03071421283542
Group 1 (Vaccinated)1.33* ± 0.082.23 ± 0.074.56 ± 0.185.10 ± 0.138.06* ± 0.177.10 ± 0.16.06 ± 0.09
Group 2 (Control)0000---

Table text extracted from the original PDF; superscript letters are shown inline. The original table image is below.

View original table image
Serum antibody titre (log2 HI units) against Newcastle disease after in ovo vaccination (n=30)↗ Enlarge
Table 1
Serum antibody titre (log2 HI units) against Newcastle disease after in ovo vaccination (n=30)

Serum antibody titre (log2 HI units) against Newcastle disease after in ovo vaccination (n=30)

Open full-size image ↗
Original paper tableSource PDF · page 2 ↗

Discussion

In ovo vaccination is the novel approach to protect birds from many respiratory diseases [15,16,19] . In current study, inactivated vaccine of Newcastle disease was given in ovo to protect birds against ND, similar research was performed by Ebrahimi et al. 2000 [20] , where 300 eggs of broiler breeders were selected for in ovo vaccination with Newcastle Disease and Avian Influenza oil emulsion vaccine. In current study, 30 SPF eggs were vaccinated and 30 eggs were kept as control. In ovo vaccination was performed on 18 th day of hatching. Vaccination procedure was successful in all eggs with 100% hatchability. Oil emulsion vaccine against Newcastle Disease could produce neonatal protection from day of hatching as the results show that antibody HI titre was obtained as 1.33 ± 0.08 as compared to that of control which was found 0 throughout the study. HI titre was found significantly different on 21 st day of vaccination compared to that of 3 rd day and 28 th day of vaccination. It indicates that Inactivated vaccine was sufficient to induce high protective level after 21 days of vaccination and it boosted after challenge at 21 days. Similar observations were found by Okwor et al. 2014 [21] , who reported that in ovo vaccination could produce effective protection in the terms of antibody titre and sustaining against challenge.

Conclusion

The study concluded that in ovo vaccination is a good alternative of other ways of vaccination, particularly against Newcastle disease as the disease is highly important and measures of effective protection are necessary. In ovo vaccination has advantage of neonatal protection with less side effects and decreased labour cost.

References

15 in the original paper
  1. Orsi MA, Doretto Jr L, Camillo SCA, Reischak D, Ribeiro SAM, Ramazzoti A, et al. Prevalence of Newcastle disease virus in broiler chickens (Gallus gallus) in Brazil. Brazilian J Microbiol. 2010; 41:349-357.
  2. Diel DJ, Susta L, Garcia SC, Killian ML, Brown CC, Miller PJ, et al. Complete genome and clinicopathological characterization of a virulent Newcastle disease virus isolate from South America. J Clin Microbiol. 2012; 50 (2): 378-387.
  3. Kahn CM. The Merck Veterinary Manual. 9th edn. Philadelphia: National Publishing Inc, 2005.
  4. Madadgar O, Karimi V, Nazaktabar A, Kazemimanesh M, Ghafari MM, Dezfouli SM, et al. A study of Newcastle disease virus obtained from exotic caged birds in Tehran between 2009 and 2010. Avian Pathol. 2013; 42(1):27-31.
  5. Moerad B. Indonesia: Disease Control. In: Copland JW (ed.), Newcastle disease in poultry: A new food pellet vaccine. ACIAR Monograph No. 1987; 5:73-76.
  6. OIE. Newcastle disease (Infection with Newcastle disease virus), 2012.
  7. Shim JB, So HH, Won HH, Mo I. Characterization of avian paramyxovirus type 1 from migratory wild birds in chickens. J Avian Pathol. 2011; 40:565-572.
  8. Xiao S, Paldurai A, Nayak B, Mirande A, Collins PL. Complete genome sequence of a highly virulent Newcastle disease virus currently circulating in Mexico. Genome Announce. 2013, 01-02.
  9. Sharma G, Greer W, Gildersleeve RP, Murray DL, Miles AM. Field safety and efficacy of in Ovo administration of HVT+SB-1 bivalent Marek's disease vaccine in commercial broilers. Avian Diseases. 1995; 39:211-217.
  10. Riaz MN, Hussain I, Akhtar M, Rasool MH, Mansoor NK, Haq SEU. Evaluation of in Ovo vaccination against infectious bursal disease virus in commercial broilers in Pakistan. International Journal of Agriculture and Biology. 2004; 6:984-986.
  11. Sharma JM, Burmester BR. Resistance to Marek's disease at hatching in chicken vaccinated as embryos with the Turkey's Herpesvirus. Avian Diseases. 1982; 26:134-149.
  12. Sharma JM. Embryo vaccination with Infectious Bursal Disease alone or in combination with Marek's disease vaccine. Avian Diseases. 1985; 29:1155-1169.
  13. Negash T, Al-Garib SO, Gruys E. Comparison of in ovo and post-hatch vaccination with particular reference to Infectious Bursal Disease. A review, Veterinary Quarterly. 2004; 26(2):76-87.
  14. Ebrahimi MM, Moghaddampour M, Tavassoli A, Shahsavandi S. Vaccination of chicks with experimental Newcastle disease and Avian Influenza oil-emulsion vaccines by ln ovo inoculation. Arch Raz lns. 2000; 51:1525.
  15. Okwor GO. Profile of maternally derived antibody in broiler chicks and in-ovo vaccination of chick embryo against Newcastle disease. World Journal of Vaccines. 2014; 4:72-80.